Details a sweeping tariff hike to 84% on Chinese imports and de minimis increases, aiming to protect U.S. economic and national security.
Discover how AI is transforming medical technology with the AI Policy Roadmap. Learn how Congress can unleash even more innovation with targeted legislation. Download your copy today!
AdvaMed®’s medtech priorities for the 119th Congress highlight opportunities to address the most important issues facing patients and the medical technology industry today.
Essential advocacy insights on how new tariffs impact the MedTech industry. Use these key messages when engaging with policymakers, industry stakeholders, and media.
A timeline of critical policy and legislative deadlines, including budget resolutions, trade discussions, and key votes that may impact MedTech and global trade policies.
This Guidance Document provides companies with direction on implementing legitimate, bona fide training and education programs.
The AdvaMed® Code of Ethics on Interactions with Health Care Professionals in China – the “AdvaMed® China Code” or “Code” – serves as a foundational charter for medical technology companies’…
The AdvaMed® Code of Ethics on Interactions with Health Care Professionals in China – the “AdvaMed® China Code” or “Code” – serves as a foundational charter for medical technology companies’…
The AdvaMed® Code of Ethics on Interactions with Health Care Professionals in China – the “AdvaMed® China Code” or “Code” – serves as a foundational charter for medical technology companies’…
Medical device manufacturers take seriously the need to continuously assess the security of their devices.